Bowang Pharmaceutical

PharmaceuticalsSeries AShanghai, China

Latest round

Series A

Last raised

Nov 2023

Total raised

$104M

Investors

9

About Bowang Pharmaceutical

Established in 2021 and based in Shanghai, China, Bowang Pharmaceutical is an RNAi drug R&D platform dedicated to the development of a new generation of RNAi drugs. The company is dedicated to the development of siRNA (Small interfering RNA) drugs. Its products are used in the field of cardiovascular diseases, rare diseases, hepatitis B, autoimmune, neurological disorders. In addition, its four oligonucleic acid programs are expected to enter clinical phase 2 in early 2024.

Who invested in Bowang Pharmaceutical

9 investors across 3 rounds

See all investors in Bowang Pharmaceutical

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 1, 2023

    Amount

    $41M

    Investors

    Locked

  2. Series A

    Mar 23, 2022

    Amount

    $63M

    Investors

    Locked

  3. Angel

    Apr 27, 2021

    Amount

    Undisclosed

    Investors

    Locked

Questions about Bowang Pharmaceutical

Who invested in Bowang Pharmaceutical?

Bowang Pharmaceutical has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Bowang Pharmaceutical raised?

Bowang Pharmaceutical has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Bowang Pharmaceutical last raise money?

Bowang Pharmaceutical's most recent round on record is a Series A, in Nov 2023.

What does Bowang Pharmaceutical do?

Established in 2021 and based in Shanghai, China, Bowang Pharmaceutical is an RNAi drug R&D platform dedicated to the development of a new generation of RNAi drugs.

Where is Bowang Pharmaceutical headquartered?

Bowang Pharmaceutical is headquartered in Shanghai, China.

Which VCs invest in companies like Bowang Pharmaceutical?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Bowang Pharmaceutical's stage. Their profiles are linked below.

Raising like Bowang Pharmaceutical? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.